Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has shared an update.
Consun Pharmaceutical Group Ltd. has announced that its subsidiaries have subscribed to wealth management products from SPD Bank and its subsidiary, SPDB Wealth Management, with a total principal amount of RMB875,500,000. These transactions, funded by the company’s idle funds, are considered discloseable under Hong Kong’s Listing Rules due to their aggregated value exceeding certain percentage thresholds, though they do not require shareholder approval.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
YTD Price Performance: 69.82%
Average Trading Volume: 2,553,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.23B
Learn more about 1681 stock on TipRanks’ Stock Analysis page.